Efficacy and Safety of Canakinumab in Patients with Cryopyrin Associated Periodic Syndrome: Results From Meta-Analysis of 5 Studies

被引：0
|
作者：
Lachmann, Helen J. [1 ]
Kuemmerle-Deschner, Jasmin B. [2 ]
Heike, Toshio [3 ]
Hara, Toshiro [4 ]
Yokota, Shumpei [5 ]
Mckernan, Phil [6 ]
Widmer, Albert [6 ]
Davis, Nicole [7 ]
Hachulla, Eric [8 ]
机构：
[1] UCL, Sch Med, London W1N 8AA, England
[2] Univ Tubingen Hosp, Dept Pediat, Div Pediat Rheumatol, Tubingen, Germany
[3] Kyoto Univ, Grad Sch Med, Dept Pediat, Kyoto, Japan
[4] Kyushu Univ, Grad Sch Med Sci, Dept Pediat, Fukuoka 812, Japan
[5] Yokohama City Univ, Grad Sch Med, Dept Pediat, Yokohama, Kanagawa 232, Japan
[6] Novartis Pharma AG, Basel, Switzerland
[7] Novartis Pharmaceut, E Hanover, NJ USA
[8] Univ Lille, Claude Huriez Hosp, Dept Internal Med, Lille, France
来源：
ARTHRITIS AND RHEUMATISM | 2012年 / 64卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
748
引用
收藏
页码：S321 / S322
页数：2
相关论文
共 50 条
  • [1] Efficacy and safety of canakinumab in cryopyrin-associated periodic syndromes: results from a Spanish cohort
    Anton, J.
    Calvo, I.
    Fernandez-Martin, J.
    Gamir, M. L.
    Merino, R.
    Jimenez-Trevino, S.
    Sevilla, B.
    Cabades, F.
    Bou, R.
    Arostegui, J. I.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2015, 33 (06) : S67 - S71
  • [2] Safety of Canakinumab in a Large Cohort of Patients with Cryopyrin-Associated Periodic Syndrome: Results From the β-Confident Registry.
    Hoffman, H.
    Kuemmerle-Deschner, J. B.
    Hawkins, P.
    van der Poll, T.
    Walker, Ulrich A.
    Rauer, B.
    Nebesky, J. M.
    Tilson, H.
    ARTHRITIS AND RHEUMATISM, 2012, 64 (10): : S78 - S78
  • [3] Canakinumab Use in Patients with Cryopyrin-Associated Periodic Syndrome: Interim Safety and Efficacy Results from Beta-Confident Registry.
    Hoffman, Hal M.
    Kuemmerle-Deschner, Jasmin B.
    Hawkins, Philip N.
    van der Poll, T.
    Walker, Ulrich A.
    Abrams, Ken
    Tilson, Hugh H.
    ARTHRITIS & RHEUMATOLOGY, 2014, 66 : S367 - S367
  • [4] Long-term safety and efficacy of Canakinumab in cryopyrin-associated periodic syndrome (CAPS) patients: Results from beta-confident registry
    Kuemmerle-Deschner J.
    Hoffman H.
    Hawkins P.N.
    van der Poll T.
    Walker U.A.
    Speziale A.
    Tilson H.H.
    Pediatric Rheumatology, 13 (Suppl 1)
  • [5] Safety Results From The Beta Confident Registry In Canakinumab-Treated Patients With Cryopyrin-Associated Periodic Syndrome.
    Hoffman, Hal
    Kuemmerle-Deschner, Jasmin B.
    Hawkins, Philip N.
    van der Poll, T.
    Walker, Ulrich A.
    Nebesky, Michael
    Abrams, Ken
    Tilson, Hugh
    ARTHRITIS AND RHEUMATISM, 2013, 65 : S1173 - S1173
  • [6] Efficacy and safety of Canakinumab (ILARIS®) in Cryopyrin-Associated Periodic Syndrome (CAPS): Interim results of an onging phase III study
    Leslie, K. S.
    Kuemmerle-Deschner, J. B.
    Lachmann, H. J.
    Hachulla, E.
    Hoyer, J.
    Smith, J.
    Kone-Paut, I.
    Braun, I.
    Widmer, A.
    Patel, N.
    Preiss, R.
    Hawkins, P. N.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2010, 130 : S9 - S9
  • [7] Canakinumab in patients with cryopyrin-associated periodic syndrome: an update for clinicians
    Kuemmerle-Deschner, Jasmin B.
    Haug, Iris
    THERAPEUTIC ADVANCES IN MUSCULOSKELETAL DISEASE, 2013, 5 (06) : 315 - 329
  • [8] Long-term safety and effectiveness of canakinumab therapy in patients with cryopyrin-associated periodic syndrome: results from the β-Confident Registry
    Walker, Ulrich A.
    Tilson, Hugh H.
    Hawkins, Philip N.
    van der Poll, Tom
    Noviello, Stephanie
    Levy, Jeremy
    Vritzali, Eleni
    Hoffman, Hal M.
    Kuemmerle-Deschner, Jasmin B.
    RMD OPEN, 2021, 7 (02):
  • [9] SAFETY RESULTS FROM THE B-CONFIDENT REGISTRY IN CANAKINUMAB-TREATED PATIENTS WITH CRYOPYRIN-ASSOCIATED PERIODIC SYNDROME (CAPS)
    Kuemmerle-Deschner, J. B.
    Tilson, H.
    Hawkins, P. N.
    van der Poll, T.
    Walker, U. A.
    Rauer, B.
    Nebesky, J. M.
    Kim, D.
    Davis, N.
    Hoffman, H.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 321 - 321
  • [10] Efficacy and Safety of Canakinumab in Patients with TNF Receptor Associated Periodic Syndrome
    Gattorno, Marco
    Obici, Laura
    Meini, Antonella
    Tormey, Vincent
    Abrams, Ken
    Davis, Nicole
    Andrews, Christopher
    Lachmann, Helen J.
    ARTHRITIS AND RHEUMATISM, 2012, 64 (10): : S322 - S322
12345